Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE

    NEXT STORY
    PM360 2019 Innovative Product Medidata Rave Coder from Medidata, a Dassault Systèmes company
    PREV STORY
    PM360 2019 Innovative Product Qollor from Watzan
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Calithera Biosciences Reports Second Quarter 2017 Financial Results and Recent Highlights

    SOUTH SAN FRANCISCO, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

    author_avatar
    NASDAQ Market News

    TLC Reports Second Quarter 2019 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    PENTAX Medical Launches the SCOPEPILOT True 3D Endoscope Navigation System in Canada

    MISSISSAUGA, Ontario, March 03, 2017 (GLOBE NEWSWIRE) -- PENTAX Medical, an industry leader in ...

    author_avatar
    NASDAQ Market News